The effect of food and nutrients on iron overload: what do we know so far?

• Published in: European journal of clinical nutrition Vol. 75; no. 12; pp. 1771 - 1780
• Main Authors: Omena, Juliana, Curioni, Cíntia, Cople-Rodrigues, Cláudia Dos Santos, Citelli, Marta
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.12.2021
• Subjects: Absorption; Ascorbic acid; Bioavailability; Development and progression; Diet; Diet therapy; Dietary supplements; Diseases; Ferritin; Ferritins; Food; Health aspects; Hemochromatosis; Hemochromatosis - complications; Hepcidin; Hepcidins - metabolism; Humans; Intestinal Absorption; Intestine; Iron; Iron - metabolism; Iron metabolism disorders; Iron Overload - etiology; Iron, Dietary - adverse effects; Medical nutrition therapy; Methods; Nutrient deficiency; Nutrients; Nutrition; Overloading; Patients; Polyphenols; Procyanidins; Regulatory mechanisms (biology); Transfusion; Vitamin C; Brazil
• ISSN: 0954-3007; 1476-5640
• DOI: 10.1038/s41430-021-00887-5

There has been no established food and nutrition guidance for diseases characterized by the presence of iron overload (IOL) yet. Hepcidin is a hormone that diminishes iron bioavailability. Its levels increase in response to increased iron stores. Hence, IOL conditions could hypothetically trigger a self-regulatory mechanism for the reduction of the intestinal absorption of iron. In addition, some food substances may modulate intestinal iron absorption and may be useful in the dietary management of patients with IOL. This scoping review aimed to systematize studies that support dietary prescriptions for IOL patients. It was carried out according to the method proposed by the Joanna Briggs Institute and the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Although the need to restrict iron in the diet of individuals with hemochromatosis is quite clear, there is a consensus that IOL diminishes the rate of iron absorption. Reduced iron absorption is also present and has been reported in some diseases with transfusion IOL, in which serum hepcidin is usually high. The consumption of polyphenols and 6-shogaol seems to reduce iron absorption or serum ferritin concentration, while procyanidins do not cause any changes. Vitamin C deficiency is often found in IOL patients. However, vitamin C supplementation and alcohol consumption should be avoided not only because they increase iron absorption, but also because they provoke toxic oxidative reactions when the iron is excessive. Dietary approaches must consider the differences in the pathophysiology and treatment of IOL diseases.